Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Violation Rate Increases for Clinical Trials - Medical Product Outsourcing

Violation Rate Increases for Clinical Trials

FDA: Many problems discovered by complaints

The violation rate for clinical trial sponsors went up in fiscal year 2007, hitting a 10-year high, and the U.S. Food and Drug Administration found many of the problems during inspections to be triggered by complaints, said the Center for Devices and Radiological Health. 

Of the 40 trial sponsors inspected by the device center’s division of bioresearch monitoring (BIMO), 33 percent were found to have significant regulatory violations. That compares with 11 percent of the 53 sponsors inspected in fiscal year 2006 that were significantly out of compliance, which was the best industry performance in 10 years. 

Device companies received eight warning letters in 2007, which is five more than in 2006. 

The BIMO division is responsible for checking on the quality and integrity of clinical trial data and ensuring that trial subjects are protected from hazards and risks. 

Of 323 BIMO inspections in fiscal year 2007, 14 percent were tagged, up from 11 percent the year before. Twenty-nine resulted in warning letters, up from 24.

For more information on preparing for BIMO inspections, visit http://stagging_mpo.rodpub.com/articles/2008/11/preparing-for-fda-bimo-inspections.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters